Post Exposure Hepatitis Treatment: An Educational Overview

Post exposure care, often called post-exposure prophylaxis or PEP, is a way clinicians may try to lower the chance that an exposure leads to infection. It is most often discussed for hepatitis A and hepatitis B, where vaccines and certain immune-based products exist. It is a conversation with a clinician, not something to figure out on your own.

Hepatitis A is generally an acute illness that usually resolves on its own. Hepatitis B and hepatitis C can become chronic infections in some people. Because these viruses differ, the approach after an exposure also differs depending on which virus may be involved.

For hepatitis C, there is no vaccine, so follow-up after a possible exposure typically centers on testing and monitoring over time. If infection is found, hepatitis C can often be treated and cleared with modern antiviral medication, and hepatitis B is effectively managed with antiviral therapy and monitoring when needed. A clinician can explain what applies to your situation.

Traditionally, care after a possible exposure begins with a clinician asking about what happened, when it happened, and what the source of the exposure may have been. They may also ask about your past vaccination history. This helps them understand which virus is a concern and how much time has passed.

For hepatitis A and B, clinicians have long used vaccination and, in some situations, immune globulin products as part of post-exposure care. Whether either is appropriate depends on your history, your health, and the type of exposure. These are medical products regulated by the FDA, and only a licensed clinician decides if they are right for you after an evaluation.

Blood testing is a common part of the process, sometimes at the time of exposure and again later, because infections may not show up right away. Workplace exposures, such as those in healthcare settings, often follow an employer's reporting process as well. People at higher risk, including those born in regions where hepatitis B or C is more common, people who received blood transfusions before 1992, and people who have injected drugs, may discuss screening with a provider without any stigma attached.

A doctor experienced in hepatitis prevention and vaccination may help you sort out what the exposure was, which viruses are relevant, and what follow-up makes sense. A visit is generally a conversation: your timeline, your vaccination records if you have them, and possibly blood tests. Because timing can matter, many people choose to call a provider promptly rather than waiting.

Helpful questions to bring include: Which hepatitis viruses should I be concerned about? Am I already vaccinated or immune? Are vaccines or other products appropriate in my case, and what is their regulatory status? What testing and follow-up would you suggest, and when?

You can also ask about vaccination for the future, about protecting household members or partners, and about what symptoms should prompt a call. You can find licensed professionals through Providers.plus, which lists providers who may help with prevention and vaccination questions.